Maureen Horton

Title: Maureen Horton: Innovator in Autoimmune Fibrosis Treatment

Introduction

Maureen Horton is a distinguished inventor based in Baltimore, MD (US). She has made significant contributions to the field of autoimmune diseases, particularly in the treatment of systemic sclerosis. Her innovative approach has the potential to change the lives of many individuals suffering from this condition.

Latest Patents

Maureen Horton holds a patent titled "Ameliorating systemic sclerosis with death receptor agonists." This patent focuses on methods and compositions for treating and preventing autoimmune fibrosis, such as systemic sclerosis (SSc; scleroderma). The method involves administering an effective amount of a death receptor agonist to a subject in need. Suitable agonists include tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL), agonistic death receptor antibodies, and their variants, analogues, or derivatives. The administration of these agonists blocks fibroblast activation and reduces myofibroblasts, thereby preventing systemic sclerosis. She has 1 patent to her name.

Career Highlights

Maureen Horton is affiliated with Johns Hopkins University, where she conducts her research and develops her innovative treatments. Her work is at the forefront of medical research, focusing on autoimmune diseases and their management.

Collaborations

Some of her notable coworkers include Martin Gilbert Pomper and Yumin Oh. Their collaborative efforts contribute to the advancement of research in the field of autoimmune diseases.

Conclusion

Maureen Horton is a pioneering inventor whose work in treating systemic sclerosis showcases her commitment to improving patient outcomes. Her innovative methods and collaborations highlight the importance of research in the medical field.